Effect of Valerian on spermatogenic, genotoxic, reproductive and biochemical changes in sex cells after chronic treatment in male Swiss albino mice

Journal of Medical Sciences

Volumn 7, Issue 2, 2007, Pages 276-283

  Al Majed, Abdulhakeem A ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Biochemical; Genotoxic; Reproductive; Sex cells; Spermatogenic; Valerian

Indexed keywords

DNA; MALONALDEHYDE; NUCLEIC ACID; PROTEIN; RNA; THIOL DERIVATIVE; VALERIAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL STRUCTURE; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; DNA CONTENT; DNA DEGRADATION; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG MEGADOSE; EPIDIDYMIS TAIL; FEMALE; GENOTOXICITY; LIPID PEROXIDATION; MALE; MOUSE; NIDATION; NONHUMAN; ORGAN WEIGHT; OXIDATIVE STRESS; PREGNANCY RATE; PROTEIN DEPLETION; REPRODUCTIVE TOXICITY; RNA ANALYSIS; SEMINAL VESICLE; SPERMATOGENESIS; SPERMATOZOON COUNT; SPERMATOZOON MOTILITY;

EID: 33947242065     PISSN: 16824474     EISSN: 18125727     Source Type: Journal    
DOI: 10.3923/jms.2007.276.283     Document Type: Article

References (41)

1. Agrawal, R.C., Y. Shukla and N.K. Mehrotra, 1997. Assessment of mutagenic potential of thiram. Food Chem. Toxicol., 35: 523-525.
2. Aldridge, S.A., 1982. Drug-induced sexual dysfunction. Clin. Pharm., 2: 141-147.
3. Al-Shabanah, O.A., 1997. Influence of captopril on spermatogenic dysfunction, spermatocyte chromosomes and dominant lethality in Swiss albino male mice. Res. Comm. Pharm. Toxicol., 2: 69-84.
4. Anderson, Jr., R.A., B.R. Willis, C. Oswald and L.J.D. Zaneveld, 1983. Ethanol-Induced male infertility: Impairment of spermatozoa. J. Pharmacol. Exp. Therap., 225: 479-485.
5. Ang-Lee, M.K., J. Moss and C.S. Yuan, 2001. Herbal medicines and perioperative care. JAMA., 286: 208-216.
6. Birgit, M., G.B. Dietz, G.F. Mahady, F. Pauli and R. Farnsworth, 2005. Valerian extract and valerenic acid are partial agonists of the 5-HT5 receptor in vitro. Mol. Brain Res., 138: 191-197.
7. Boniel, T. and P. Dannon, 2001. The safety of herbal medicines in the psychiatric practice. Harefuah, 140: 780-783.
8. Bregman, A.A., 1983. In Laboratory Investigations and Cell Biology, John, Willey and Sons, New York, pp: 51-60.
9. Cas, H., 2004. Herbs for the nervous system: Ginkgo, kava, valerian, passion flower. Seminars in Integ. Med., 2: 82-88.
10. Chan, P.K., G.P. O'Hara and A.W. Hayes, 1986. Principles and Methods for Acute and Sub-Chronic Toxicity, In: Principles and Methods of Toxicology. Hayes, A.W. (Ed.), Raven Press, New York, pp: 17.
11. Cheng, B., C.T. Hung and W. Chiu, 2002. Herbal medicine and anaesthesia. Hong Kong Med. J., 8: 123-130.
12. Chenoweth, P.J., C.C. Chase, Jr. C.A. Risco and R.E. Larsen, 2000. Characterization of gossypol-induced sperm abnormalities in bulls. Theriogenology, 53: 1193-1203.
13. Dunaev, V.V., S.D. Trzhetsinskii, V.S. Tishkin, N.S. Fursa and V.I. Linenko, 1987. Biological activity of the sum of the valepotriates isolated from Valerian alliariifolia. Farmakol. Toksikol., 50: 33-37.
14. Evans, E.P., G. Breckon and C.E. Ford, 1964. An air drying method for meiotic preparation from mammalian testes. Cytogenet, 3: 289.
15. Fabbri, A. and M. Caprio, 2003. A. Aversa: Pathology of erection. J. Endocrinol. Invest. 26 (3 Suppl): 87-90.
16. Green, S., A. Auletta, J. Fabricant, R. Kapp, M. Manandhar, C.J. Sheu, J. Springer and B. Whitfield, 1985. Current status of bioassays in genetic toxicology-the dominant lethal assay: A report of the U.S. Environmental Protection Agency Gene-Tox Program. Mutat. Res., 154: 49-67.
17. Harper, A., D.J. Kerr, A. Gescher and J.K. Chipman, 1999. Antioxidant effects of isoflavonoids and lignans and protection against DNA oxidation. Free Rad. Res., 31: 149-160.
18. Hodges, P.J. and P.C. Kam, 2002. The peri-operative implications of herbal medicines. Anaesth., 57: 889-899.
19. Hui-Lian, W., Z. Dong-Fang, L. Zhao-Feng, L. Yang, L. Qian-Rong and W. Yu-Zhen, 2002. In vitro study on the genotoxicity of dichloromethane extrcts of valerian (DEV) in human endothelial ECV304 cells and the effect of vitamins E and C in attenuating the DEV-induced DNA damages. Toxicol. Applied Pharmacol., 188: 36-41.
20. Imaoka, S., M. Osada, Y. Minamiyama, T. Yukimura, S. Toyokuni, S. Takemura, T. Hiroi and Y. Funae, 2004. Role of Phenobarbital-inducible cytochrome P450s as a source of active oxygen species in DNA-oxidation. Cancer Lett., 203: 117-125.
21. Keochanthala-Bounthanh, C., M. Haag-Berrurier, J.P. Beck and R. Anton, 1990. Effects of thiol compounds versus the cytotoxicity of valepotriates on cultured hepatoma cells. Planta Med., 56: 190-192.
22. Lefebvre, T., B.C. Foster, C.E. Drouin, A. Krantis, J.F. Livesey and S.A. Jordan, 2004. In vitro activity of commercial valerian root extracts against human cytochrome P450 3A4. J. Pharm. Pharmaceut. Sci., 7: 265-273.
23. Leuschner, J., J. Muller and M. Rudmann, 1993. Characterization of the central nervous depressant activity of a commercially available valerian root extract. Arzneim. Forsch., 43: 638-641.
24. Malva, J.O., S. Santos and T. Macedo, 2004. Neuroprotective properties of Valeriana officinalis extracts. Neurotox. Res., 6: 131-140.
25. Montero, R., L. Serrano, V.M. Davita and A. Ito, 2003. Plancarte: Infection of rats with Taenia taeniformis metacestodes increases hepatic CYP450, induces the activity of CYP1A1, CYP2B1 and COH isoforms and increases the genotoxicity of the procarcinogens benzo[a]pyrene, cyclophosphamide and aflatoxin B(1). Mutagenesis, 18: 211-216.
26. Ohkawa, H., N. Ohishi and K. Yagi, 1979. Assay of lipid peroxides in animal tissues by thiobarbituric acid reactions. Anal. Biochem., 95: 351-358.
27. Osswald, K., T.W. Becker, M. Grimm, G. Jahreis and B.L. Pool-Zobel, 2000. Inter- and intra-individual variation of faecal water genotoxicity in human colon cells. Mutat. Res., 472: 59-70.
28. Perez-Sanchez, F., L. Tablado and C. Soler, 1997. Sperm morphological abnormalities appearing in the male rabbit reproductive tract. Theriogenology, 47: 893-901.
29. Petrie, W.M., 1980. Sexual effects of anti-depressants and psychomotor stimulant drugs. Med. Probl. Pharmaco-Psychiatry, 15: 77-90.
30. Piccinelli, A.L., S. Arana, A. Caceres, R. di Villa Bianca, R. Sorrentino and L. Rastrelli, 2004. New lignans from the roots of Valeriana prionophylla with antioxidative and vasorelaxant activities. J. Natural Prod., 67: 1135-1140.
31. Sapone, A., A. Affatato, D. Canistro, M. Broccoli, S. Trespidi, L. Pozzetti, G.L. Biagi, G. Cantelli-Forti and M. Paolini, 2003. Induction and suppression of cytochrome P450 isoenzymes and generation of oxygen radicals by procymidone in liver, kidney and lung of CD1 mice. Mutat. Res., 527: 67-80.
32. Schacterle, G.R. and R.L. Pollack, 1973. A simplified method for quantitative assay for small amount of proteins in biological materials. Anal. Biochem., 51: 654-655.
33. Schleismacher, E., 1970. The Activity of Alkylating Agents: II. Histological and Cytogenetic Findings in Spermatogenesis. In: Chemical Mutagenesis in Mammals and Man. Vogel, F. and G. Rohrborn (Eds.), Springer-Veralag, N.Y., pp: 317-341.
34. Sedlak, J. and R.H. Lindsay, 1968. Estimation of total protein-bound and non-protein sulfhydryl groups in tissue with Ellman's reagent. Anal. Biochem., 25: 192.
35. Tufik, S., K. Fujita, L. Seabra, L. Mde and L. Lobo, 1994. Effects of a prolonged administration of valepotriates in rats on the mothers and their offspring. J. Ethnopharmacol., 41: 39-44.
36. Von der Hude, W., M. Scheutwinkel-Reich, R. Braun and W. Dittmar, 1985. In vitro mutagenicity of valepotriates. Arch. Toxicol., 56: 267-271.
37. Von der Hude, W., M. Scheutwinkel-Reich and R. Braun, 1986. Bacterial mutagenicity of the tranquilizing constituents of Valerianaceae roots. Mutat. Res., 169: 23-27.
38. Watanabe, T. and A. Endo, 1991. Effects of selenium deficiency on sperm morphology and spermatocyte chromosomes in mice. Mutat. Res., 262: 93-99.
39. Wauthier, V., R.K. Verbeeck and P.B. Calderon, 2004. Age-related changes in the protein and mRNA levels of CYP2E1 and CYP3A isoforms as well as in their hepatic activities in Wistar rats. What role for oxidative stress. Arch. Toxicol., 78: 131-138.
40. Wyrobek, A.J. and W.R. Bruce, 1975. Chemical induction of sperm abnormalities in mice. Proc. Natl. Acad. Sci., 72: 4425-4429.
41. Wyrobek, A.J., L.A. Gordon, J.G. Burkhart, M.W. Francis, R.W. Kapp, Jr., G. Letz, H.V. Mailing, J.C. Topham and M.D. Whorton, 1983. An evaluation of the mouse sperm morphology tests and other sperm tests in non-human animals. Mutat. Res., 115: 1-72.